Hypertonic saline (HS) resuscitation has been reported to prevent lung dama
ge by suppressing neutrophil activation in animal models. Data on the effec
tiveness of HS to prevent organ damage in the clinical setting are inconsis
tent. We investigated whether the timing of HS administration relative to n
eutrophil activation could affect its potential to block neutrophil respons
es. Different likely clinical circumstances were simulated in vitro by expo
sing human neutrophils to HS at different time points before and after acti
vation with N-formyl-methionyl-leucyl-phenylalanine (fMLP). The in vivo eff
ect of using HS as a secondary resuscitation fluid was determined with a mo
use model of hemorrhage. BALB/c mice were hemorrhaged (40 +/- 5 mmHg) for 1
h and partially resuscitated with HS or Lactated Ringer's (LR) 20 min befo
re completing resuscitation with LR or HS, respectively. Neutrophil activat
ion parameters were determined 2 h after complete resuscitation and lung da
mage was assessed after 24 h. The length of exposure to physiologically rel
evant HS levels (20 mM) determined the suppressive effect on in vitro neutr
ophil superoxide formation. HS treatment caused a transient state of suppre
ssion during which neutrophil activation was suppressed; however, HS was un
able to suppress cells that were stimulated with fMLP before HS was added.
Accordingly, in viva lung damage was greater in animals that received HS af
ter they had been partially resuscitated with LR compared to mice that rece
ived HS before LR (P < 0.05). We conclude that timing of exposure to HS aff
ects neutrophil responses in vitro and may reduce the potential of HS resus
citation to prevent lung injury in vivo.